The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

Close to 50,000 Americans will die from colorectal cancer (CRC) in 2016, making it the second-leading cause of cancer-related death in this country (behind only lung cancer).1 What makes the statistic ...

Overall, the incidence of colorectal cancer has decreased over the decades, largely in part due to the use of screening modalities, such as colonoscopy.

Findings compared with three opt-in screening strategies among average-risk adults aged 45 to 49 years. HealthDay News — Mailing a stool-based test directly to people’s homes is the most effective ...

Cologuard and other at-home tests are not intended for and have not been tested in people with Lynch syndrome. Furthermore, ...

A brief research report compared screening costs per early-detected colorectal cancer (CRC) case among fecal immunochemical tests (FIT), multitarget stool DNA tests (MSDT) and next-generation MSDTs (N ...

An investigational multitarget stool DNA test for screening colorectal cancer detects significantly more cancers than the currently available fecal immunochemical test (FIT), researchers report. But ...

(BPT) - Recently, Minnesotans have been receiving unsolicited, unrequested at-home colon cancer screening kits from health insurers, without a doctor's input. If you received one in the mail, you ...

FIT outperformed cfDNA in detecting advanced precancerous colorectal lesions, showing higher sensitivity and specificity. Blood-based tests offer easier implementation and potentially higher adherence ...

WEDNESDAY, May 14, 2025 (HealthDay News) -- Multitarget stool DNA test (MSDT)- and next-generation MSDT (N-G MSDT)-based screening have higher costs per detected advanced neoplasia case or early ...